Each week, PatientWing covers new discoveries that change what's possible in medicine. This week, we're looking at a major step forward in pancreatic cancer treatment, the first-ever look at the brain cells behind depression, why some 80-year-olds remember like people decades younger, and an early study using sound waves to destroy viruses.
Here's what's happening in health research.
For decades, scientists tried and failed to target a mutation called KRAS. KRAS drives more than 90% of pancreatic cancer cases, and was so hard to attack that researchers called it "undruggable."
This week, that changed.
Revolution Medicines shared Phase III trial results for a pill called daraxonrasib. It's the first drug of its kind to successfully target RAS mutations in pancreatic cancer. In a global trial, patients taking daraxonrasib lived a median of 13.2 months. Patients on standard chemotherapy lived 6.7 months. That's nearly double the survival time.
KRAS mutations get stuck in the "on" position, telling cells to keep growing without stopping. Daraxonrasib blocks that signal.
The trial has closed enrollment. On May 1, the FDA issued a "safe to proceed" letter for an expanded access program, meaning eligible patients who can't join a trial may still be able to get the drug. Full data will be presented at the ASCO Annual Meeting later this month.
For patients and families, the Pancreatic Cancer Action Network (PanCAN) offers free biomarker testing through its Know Your Tumor program. Their Case Managers can help with questions about treatment, expanded access, and trials.
📰 Read more: Pancreatic Cancer Action Network, May 2026
More than 264 million people live with depression worldwide. It's one of the leading causes of disability on the planet. But until now, we didn't know which brain cells were involved.
Researchers at McGill University and the Douglas Institute changed that. Their study, published in Nature Genetics, identified two types of brain cells that behave differently in people with depression.
The team studied donated brain tissue and used advanced tools to look at gene activity inside individual cells. They found:
• A group of neurons that helps regulate mood and stress response
• A subtype of microglia, the brain's immune cells that control inflammation
Both showed measurably different gene activity in people with depression.
This is a big deal for two reasons. First, it gives researchers a clearer biological target. Instead of treating depression as a vague chemical imbalance, scientists can ask what's happening in these specific cells. Second, it adds to the growing case that depression is a biological condition rooted in real, measurable changes, not a character flaw.
📰 Read more: ScienceDaily / Nature Genetics, April 2026
For most people, some memory loss with age feels unavoidable. But a group of people over 80, known as "SuperAgers," score on memory tests at the level of people 20 to 30 years younger.
After 25 years of research at Northwestern University, scientists are figuring out why.
Two patterns stand out. Some SuperAgers don't develop the plaques and tangles linked to Alzheimer's at all. Others develop them but seem resistant to their effects.
Their brains also look different. Typical aging brains thin over time. SuperAger brains barely shrink. One region tied to decision-making and emotion, the anterior cingulate cortex, is sometimes thicker in SuperAgers than in younger adults.
They also have more specific neurons linked to social behavior. That fits with one of the most consistent findings: SuperAgers tend to be highly social and maintain close relationships throughout life.
This isn't a recipe for becoming a SuperAger. But it shows exceptional memory in old age is biologically possible, and it opens new doors for treatments that strengthen cognitive resilience.
📰 Read more: ScienceDaily / Northwestern University, April 2026
This one is early-stage science, but the concept is striking enough to be worth knowing about. Researchers at the University of São Paulo in Brazil published a study in Scientific Reports showing that high-frequency ultrasound (the kind already used safely in diagnostic medical imaging, can physically disrupt the structural integrity of two enveloped respiratory viruses: SARS-CoV-2 and Influenza A (H1N1)).
This one is early-stage, but striking enough to share.
Researchers at the University of São Paulo found that high-frequency ultrasound (the same kind used in medical imaging) can physically break apart two respiratory viruses: SARS-CoV-2 and Influenza A (H1N1). The study was published in Scientific Reports.
Here's how it works. At about 7.5 MHz, sound waves match the natural vibration of the virus's outer shell. The shell fragments and ruptures, similar to how a soprano can shatter glass at the right pitch.
Images after treatment showed virus surfaces collapsed and deformed. Infectivity in lab cell models dropped significantly. The process didn't heat the surrounding medium or change its chemistry, suggesting the damage was specific to the virus.
One important caveat: this was done in a lab dish, not a living body. There's a long road from "this works in a petri dish" to "this could treat human infections."
Still, the implications are interesting. Ultrasound is widely available, safe, and can reach deep tissue without surgery. If validated in animals and humans, it could become a completely new type of antiviral tool, one that works through physics, not chemistry.
📰 Read more: Nature / Scientific Reports, February 2026
This week's stories stretch from one of the most hopeful moments in cancer treatment to early physics-meets-virology research that could shape medicine years from now. Two of them shift how we understand the brain: one showing depression has areal biological signature, the other reminding us that aging brains can be more resilient than we expect.
Each is worth paying attention to.
Curious what breakthroughs like these look like from the patient side? Our Patient Stories collection features advocates sharing their journeys, what helped them, and what they wish they'd known earlier. Find one that speaks to you.
For more on what's next in medicine, head on to the PatientWing Blog for more pieces on new discoveries.
